Company Valuation: IOL Chemicals and Pharmaceuticals Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2023 2024 2025 2026 2027 2028
Market Cap 1 16,608 21,222 17,964 21,354 57,649 -
Change - 27.78% -15.35% 18.87% 169.97% -
Enterprise Value (EV) 16,608 21,222 17,964 21,354 57,649 57,649
Change - 27.78% -15.35% 18.87% 169.97% 0%
P/E 11.9x 15.8x 17.8x 15.5x 26.2x 18.9x
PBR 1.1x 1.32x 1.06x 1.19x 2.94x 2.65x
PEG - -4.68x -0.7x 0.4x 0.4x 0.5x
Capitalization / Revenue 0.75x 1x 0.86x 0.92x 2.1x 1.83x
EV / Revenue 0x 0x 0x 0x 2.1x 1.83x
EV / EBITDA 0x 0x 0x 0x 15.8x 11.9x
EV / EBIT 0x 0x 0x 0x 18.5x 13.4x
EV / FCF -0x 0x -0x 0x 20.8x 31.8x
FCF Yield -5.39% 0.78% -1.94% 1.94% 4.81% 3.15%
Dividend per Share 2 0.8 1 4 - - -
Rate of return 1.41% 1.38% 6.54% - - -
EPS 2 4.74 4.58 3.44 4.69 7.5 10.4
Distribution rate 16.9% 21.8% 116% - - -
Net sales 1 22,171 21,328 20,792 23,191 27,424 31,525
EBITDA 1 2,257 2,306 2,023 2,690 3,647 4,860
EBIT 1 2,051 1,677 1,303 1,887 3,123 4,295
Net income 1 1,391 1,344 1,011 1,376 2,198 3,060
Net Debt - - - - - -
Reference price 2 56.58 72.30 61.20 72.75 196.40 196.40
Nbr of stocks (in thousands) 293,528 293,528 293,528 293,528 293,528 -
Announcement Date 4/28/23 5/14/24 5/16/25 5/20/26 - -
1INR in Million2INR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
27.23x - - - 626M
33.65x12.19x24.78x0.59% 1,055B
30.17x6.71x18.78x1.98% 654B
33.43x7.82x16.17x2.59% 467B
19.59x4.78x11.84x2.78% 348B
20.4x5.31x13.17x3.01% 275B
21.19x4.39x12.5x2.01% 258B
26.19x6.82x12.15x2.43% 224B
-45.65x6.64x25.94x2.18% 187B
11.33x4.13x8.58x4.44% 171B
Average 17.75x 6.53x 15.99x 2.45% 363.9B
Weighted average by Cap. 24.18x 7.87x 18.13x 1.96%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. IOLCP Stock
  4. Valuation IOL Chemicals and Pharmaceuticals Limited